T14.SI - Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

SES - SES Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 3.64B
Enterprise value 3.26B
Trailing P/E 12.53
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.31
Price/book (mrq)1.65
Enterprise value/revenue 0.40
Enterprise value/EBITDA 2.95

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 398.11%
S&P500 52-week change 32.74%
52-week high 32.4400
52-week low 30.9250
50-day moving average 32.0346
200-day moving average 31.3312

Share statistics

Avg vol (3-month) 3519.89k
Avg vol (10-day) 3222k
Shares outstanding 5200M
Implied shares outstanding 6N/A
Float 8426.62M
% held by insiders 10.00%
% held by institutions 10.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.16
Forward annual dividend yield 47.50%
Trailing annual dividend rate 31.12
Trailing annual dividend yield 351.61%
5-year average dividend yield 44.61
Payout ratio 436.52%
Dividend date 3N/A
Ex-dividend date 426 May 2023
Last split factor 22:1
Last split date 330 Jun 2010

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 12.48%
Operating margin (ttm)9.81%

Management effectiveness

Return on assets (ttm)5.17%
Return on equity (ttm)15.68%

Income statement

Revenue (ttm)8.51B
Revenue per share (ttm)11.05
Quarterly revenue growth (yoy)14.00%
Gross profit (ttm)N/A
EBITDA 947.26M
Net income avi to common (ttm)1.06B
Diluted EPS (ttm)0.1900
Quarterly earnings growth (yoy)100.80%

Balance sheet

Total cash (mrq)3.46B
Total cash per share (mrq)4.47
Total debt (mrq)606.7M
Total debt/equity (mrq)8.75
Current ratio (mrq)2.22
Book value per share (mrq)8.93

Cash flow statement

Operating cash flow (ttm)785.39M
Levered free cash flow (ttm)679.29M